Abstract
BackgroundTreatment with naturally occurring antitumor T cells, or cells genetically modified to express their receptors (TCRs), has shown efficacy in patients with advanced malignancies.1–3 Previous studies have demonstrated success in...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have